Literature DB >> 15331189

Pulmonary sarcoidosis.

Robert P Baughman1.   

Abstract

Pulmonary sarcoidosis is one of the most common causes of idiopathic interstitial lung disease. Clinical presentation can range from asymptomatic to respiratory failure. Although some patients never require therapy, many patients with pulmonary sarcoidosis become symptomatic enough to require therapy. Treatment options include corticosteroids.In the past few years, alternatives to corticosteroids have been developed,especially for patients with a chronic condition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331189     DOI: 10.1016/j.ccm.2004.04.006

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  16 in total

1.  Effect of smoking and gender on pulmonary function and clinical features in sarcoidosis.

Authors:  Willane Krell; Julie M Bourbonnais; Rajat Kapoor; Lobelia Samavati
Journal:  Lung       Date:  2012-07-08       Impact factor: 2.584

2.  The confabulatory semiotics: naming and cognition of diseases by pathologists.

Authors:  Alejandro Peralta Soler; Juana Soler de Peralta
Journal:  Med Health Care Philos       Date:  2005

3.  An unusual case of granulomatous lung disease. A clinical pathology conference held by the Department of Rheumatology at Hospital for Special Surgery.

Authors:  Deborah Alpert; Douglas B Flieder; Doruk Erkan; Anne R Bass
Journal:  HSS J       Date:  2006-09

4.  Using TNF-alpha antagonist adalimumab for treatment for multisystem sarcoidosis: a case study.

Authors:  Tobias Lahmer; Andreas Knopf; Ines Lanzl; Uwe Heemann; Klaus Thuermel
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

5.  Stroke Presenting as a Complication of Sarcoidosis in an Otherwise Asymptomatic Patient.

Authors:  Muhamad Memon; Muhammed AlHazza; Humariya Heena
Journal:  Cureus       Date:  2018-03-26

6.  Profile of respiratory problems in patients presenting to a referral pulmonary clinic.

Authors:  Angira Dasgupta; Anirban Bagchi; Saikat Nag; Sujan Bardhan; Parthasarathi Bhattacharyya
Journal:  Lung India       Date:  2008-01

7.  Sarcoidosis manifesting as a pseudotumorous renal mass.

Authors:  Scott Goldsmith; Matt Harris; Kurt Scherer; Samer Al-Quran; Elizabeth Vorhis
Journal:  J Radiol Case Rep       Date:  2013-05-01

8.  Exhaled breath markers of alveolar macrophage activity in sarcoidosis.

Authors:  Nitin Mohan; Rabeya Akter; Katherine Bryant; Cristan Herbert; Sharron Chow; Paul S Thomas
Journal:  Inflamm Res       Date:  2016-03-23       Impact factor: 4.575

9.  Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis.

Authors:  Vyacheslav Palchevskiy; Nastran Hashemi; Stephen S Weigt; Ying Ying Xue; Ariss Derhovanessian; Michael P Keane; Robert M Strieter; Michael C Fishbein; Jane C Deng; Joseph P Lynch; Robert Elashoff; John A Belperio
Journal:  Fibrogenesis Tissue Repair       Date:  2011-04-04

10.  Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis.

Authors:  José Luis Callejas-Rubio; Lourdes López-Pérez; Norberto Ortego-Centeno
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.